The in vitro diagnostics (IVD) market is revolutionizing the global diagnostic landscape, reshaping how healthcare professionals detect, monitor, and manage diseases. IVD encompasses medical tests performed outside the human body, using samples like blood, tissue, or other bodily fluids.
The IVD industry isn’t just transforming healthcare; it’s creating significant business opportunities. Consider these compelling stats:
The In Vitro Diagnostics: Technologies and Global Markets is grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029. North America is driving growth due to increasing healthcare expenditures.